Cargando…
Circulating CD4(+)CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney Transplantation
Proinflammatory CD4(+) T cells without the costimulatory molecule CD28 (CD4(+)CD28null T cells) are expanded in patients with end-stage renal disease (ESRD) and associated with atherosclerotic vascular events (AVE). In a prospective study, the number of circulating CD4(+)CD28null T cells was establi...
Autores principales: | Betjes, Michiel G. H., Weimar, Willem, Litjens, Nicolle H. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830856/ https://www.ncbi.nlm.nih.gov/pubmed/24288592 http://dx.doi.org/10.1155/2013/841430 |
Ejemplares similares
-
High numbers of differentiated CD28null CD8+ T cells are associated with a lowered risk for late rejection and graft loss after kidney transplantation
por: Betjes, Michiel G. H., et al.
Publicado: (2020) -
Loss of CD28 on Peripheral T Cells Decreases the Risk for Early Acute Rejection after Kidney Transplantation
por: Dedeoglu, Burç, et al.
Publicado: (2016) -
Expression of Senescence Marker TIGIT Identifies Polyfunctional Donor-Reactive CD4+ T Cells Preferentially Lost After Kidney Transplantation
por: van der List, Amy C. J., et al.
Publicado: (2021) -
Differential effects of age, cytomegalovirus-seropositivity and end-stage renal disease (ESRD) on circulating T lymphocyte subsets
por: Litjens, Nicolle HR, et al.
Publicado: (2011) -
pERK-dependent defective TCR-mediated activation of CD4(+) T cells in end-stage renal disease patients
por: Huang, Ling, et al.
Publicado: (2017)